List of Top Upcoming Stem Cells Conferences in London, UK, EU and USA in 2026

The second half of 2026 brings a packed calendar for anyone working across stem cell science, cell and gene therapy, digital health, and regenerative medicine. From London's growing cluster of health-tech and life-science gatherings to the major European and North American translational meetings running through the autumn, this list rounds up the events worth putting on your calendar — where they're happening, when, and what each one focuses on.

Digital Health World Congress leads the list this year, reflecting how closely digital health, AI-enabled diagnostics, and cell and gene therapy commercialisation now overlap on the same conference floors — many of the same NHS, pharma, and biotech decision-makers attend both worlds.

List of Top Upcoming Stem Cells Conferences in London, UK, EU and USA in 2026

Full profiles for each event follow below.

1. Digital Health World Congress — London, UK | Nov 23–24, 2026

The Digital Health World Congress returns to London in November 2026 as the UK's flagship gathering for the convergence of artificial intelligence, mobile health, and large-scale digital transformation within healthcare systems. With 250-plus delegates drawn from NHS leadership, health tech founders, pharma digital teams, and clinical informatics specialists, the congress has become a natural crossover point for regenerative medicine and cell-therapy companies exploring AI-driven diagnostics, remote monitoring, and data infrastructure for advanced therapies. Sessions typically cover AI in clinical decision-making, interoperability, digital therapeutics, and health system modernisation — all themes increasingly relevant to how stem cell and gene therapy programmes are monitored and scaled post-approval.

2. ICSCRM — International Conference on Stem Cells and Regenerative Medicine — London, UK | Sept 23–24, 2026

This academically oriented conference brings together researchers, clinicians, and industry practitioners for a two-day programme spanning organ-on-a-chip technology, allogeneic cell therapies, cartilage and tissue repair, and translational regenerative medicine. It's positioned as an interdisciplinary platform where early findings and applied clinical work sit side by side, with opportunities for abstract and poster submissions ahead of the event.

3. London Stem Cell Network (LSCN) Annual Symposium — London, UK | Mid-November 2026 (TBC)

Hosted in the UCL orbit, the LSCN symposium is the UK capital's core academic networking event for stem cell biology. It draws principal investigators, postdocs, and PhD researchers from London's dense cluster of universities and research institutes for a day of talks, poster sessions, and cross-lab collaboration. Exact dates are typically confirmed closer to autumn, so it's worth watching the network's channels for the finalised programme.

4. COSTEM — 11th Congress on Controversies in Stem Cell Transplantation and Cellular Therapies — Berlin, Germany | Oct 1–4, 2026

COSTEM takes a debate-driven format rather than a standard lecture series, pairing speakers to argue opposing positions on unresolved questions in transplantation medicine — from graft-versus-host disease management to conditioning regimens and donor selection. It's a strong pick for clinicians and researchers who want to see live scientific disagreement worked through rather than a single consensus narrative presented from the podium.

5. CSRM — 3rd International Conference on Cell Science and Regenerative Medicine — Paris, France | Oct 26–27, 2026

Now in its third edition after Porto and Barcelona, CSRM 2026 moves to Paris with a hybrid in-person and virtual format. The programme centres on cellular repair mechanisms, biomaterials, gene editing, tissue engineering, and precision medicine, with keynote sessions aimed at both academic and industry audiences working across the translational pipeline.

6. ESGCT 33rd Annual Congress — Hamburg, Germany | Oct 27–30, 2026

The European Society of Gene and Cell Therapy's annual congress is one of the continent's most substantial gatherings for advanced therapy science, run this year in collaboration with the German Society for Gene Therapy (DG-GT). Expect a heavily abstract-driven four-day programme covering vector design, genome editing, CMC and manufacturing, and clinical translation of gene and cell therapies, alongside a public-facing day presenting key concepts to a general audience.

7. Cell & Gene Meeting on the Mesa — Phoenix, AZ, USA | Oct 5–7, 2026

Organised by the Alliance for Regenerative Medicine, Meeting on the Mesa is the commercial and dealmaking anchor of the US cell and gene therapy calendar. It draws over 1,500 attendees — more than 30% at C-level — for structured one-on-one partnering meetings, panels on clinical trial design, alternative payment models, and manufacturing scale-up. This is less an academic conference and more a business-development venue for companies navigating commercialisation hurdles in advanced therapies.

8. Stem Cell & Developmental Biology Early Career Symposium — Seattle, WA, USA | Sept 23–25, 2026

Hosted at the Allen Institute, this symposium is built specifically for early-career researchers — graduate students, postdocs, and new faculty — working in developmental biology and stem cell platforms. The smaller, focused format favours mentorship, career-development sessions, and close engagement with speakers, making it a strong choice for those building a research network rather than seeking large-scale industry exposure.

9. Till & McCulloch Meetings (TMM 2026) — Toronto, Canada | Nov 2–4, 2026

Named after the Canadian scientists credited with the original discovery of stem cells, TMM is Canada's leading regenerative medicine conference and draws significant US participation given its proximity and shared research networks. The 2026 programme is expected to focus on next-generation cell manufacturing, immunotherapy pipelines, and clinical translation, continuing the meeting's long-standing role as a bridge between fundamental stem cell science and applied cell therapy.

Choosing the right event for your priorities

With this many conferences competing for the same autumn calendar window, it helps to sort by what you're actually trying to get out of attendance:

• For NHS, digital health, and AI-in-healthcare crossover — Digital Health World Congress in London is the clearest fit, especially for teams working on data infrastructure or AI tools that support cell and gene therapy delivery.
• For deal-making and commercialisation — Cell & Gene Meeting on the Mesa in Phoenix remains the most business-focused option, built around structured partnering meetings rather than lecture tracks.
• For pure academic science and early-career networking — the Seattle Early Career Symposium and the LSCN Annual Symposium in London are the smaller, more intimate options.
• For clinical translation debate — COSTEM's adversarial format in Berlin stands apart from the standard keynote-and-panel structure used elsewhere.
• For breadth across gene therapy specifically — ESGCT in Hamburg is the largest dedicated European gene and cell therapy congress on this list.

Why this year's calendar looks different

Two shifts stand out in the 2026 conference landscape compared with previous years. First, digital health and AI infrastructure events — once treated as a separate track from cell and gene therapy — are drawing an overlapping audience. NHS digital leads, health system CIOs, and pharma data teams increasingly sit in the same rooms as regenerative medicine scientists, because the practical challenges of scaling advanced therapies (patient monitoring, real-world evidence, manufacturing traceability) are now data problems as much as biological ones. That's part of why an event like Digital Health World Congress belongs on a list built primarily around stem cell science — the delegate overlap is real and growing.

Second, the centre of gravity for commercially focused meetings has shifted further toward structured partnering formats rather than open lecture programmes. Cell & Gene Meeting on the Mesa is the clearest example: it explicitly organises itself around one-on-one meetings between developers, investors, and service providers rather than around a traditional keynote track. Expect more conferences across both the US and Europe to adopt this hybrid science-plus-dealmaking format as the sector matures from early discovery into commercial-stage therapies.

Planning ahead: submission deadlines and registration windows

Most of the academic and society-run meetings on this list — ICSCRM, CSRM, ESGCT, and the Seattle Early Career Symposium among them — open abstract submission windows several months before the event itself, often with early-bird registration discounts closing well ahead of the conference dates. Commercial and industry-facing events such as Cell & Gene Meeting on the Mesa and Digital Health World Congress tend to work on a rolling registration model instead, with sponsorship and exhibitor packages typically selling out first. If you're planning to submit research, secure a speaking slot, or book a sponsorship package rather than simply attend, it's worth checking each event's official site directly, since dates and deadlines are routinely updated as the calendar year progresses.

For teams weighing which events justify the travel budget, a practical filter is to separate "must attend in person" events — where partnering meetings, exhibitor floors, or debate-style sessions reward being physically present — from events that publish strong post-conference content and could be followed remotely instead. Several of the larger congresses, including ESGCT and COSTEM, publish programme abstracts and recorded sessions after the event, which can be a reasonable substitute for smaller teams unable to attend every stop on the calendar.

Final thoughts

2026's stem cell and regenerative medicine conference calendar spans everything from tightly focused academic symposiums to large commercial partnering events, with London holding its own as a genuine hub — not just for classic stem cell science, but increasingly for the digital health and AI infrastructure layered on top of it. Whichever events you shortlist, most open registration and abstract submission windows several months ahead of the event date, so it's worth confirming current deadlines directly on each conference's official site before finalising travel plans.

Sources include company disclosures, regulatory filings, analyst reports, and industry briefings.

Related Coverage

• More Pharma Analysis
• Latest Technology News